These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9396390)

  • 1. Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygenase-1 and 5-lipoxygenase inhibitors.
    Laufer S; Striegel HG; Neher K; Zechmeister P; Donat C; Stolingwa K; Baur S; Tries S; Kammermeier T; Dannhardt G; Kiefer W
    Arch Pharm (Weinheim); 1997 Oct; 330(9-10):307-12. PubMed ID: 9396390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type.
    Ulbrich H; Fiebich B; Dannhardt G
    Eur J Med Chem; 2002 Dec; 37(12):953-9. PubMed ID: 12660020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    Fiorucci S; Meli R; Bucci M; Cirino G
    Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors.
    Bosch J; Roca T; Catena JL; Llorens O; Pérez JJ; Lagunas C; Fernández AG; Miquel I; Fernández-Serrat A; Farrerons C
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1745-8. PubMed ID: 10937738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal anti-inflammatory agents, Part 19. E-2-pyrrolizin-5-yl acrylic acids as potent dual or selective inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W; Nowe U
    Arch Pharm (Weinheim); 1995 Sep; 328(9):681-6. PubMed ID: 7487426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyrrole moiety as a template for COX-1/COX-2 inhibitors.
    Dannhardt G; Kiefer W; Krämer G; Maehrlein S; Nowe U; Fiebich B
    Eur J Med Chem; 2000 May; 35(5):499-510. PubMed ID: 10889329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
    Sud'ina GF; Pushkareva MA; Shephard P; Klein T
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-inflammatory activity of chalcone derivatives.
    Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
    Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
    Bracher F; Krauss J; Laufer S
    Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
    Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
    Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2.
    Sui Z; Guan J; Ferro MP; McCoy K; Wachter MP; Murray WV; Singer M; Steber M; Ritchie DM; Argentieri DC
    Bioorg Med Chem Lett; 2000 Mar; 10(6):601-4. PubMed ID: 10741562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
    Gay RE; Neidhart M; Pataky F; Tries S; Laufer S; Gay S
    J Rheumatol; 2001 Sep; 28(9):2060-5. PubMed ID: 11550975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal antiinflammatory agents, XVIII: C-5 functionalized 6,7-diphenyl-2,3-dihydro-1H-pyrrolizines as inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W
    Arch Pharm (Weinheim); 1994 Aug; 327(8):509-14. PubMed ID: 7944906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.
    Barbey S; Goossens L; Taverne T; Cornet J; Choesmel V; Rouaud C; Gimeno G; Yannic-Arnoult S; Michaux C; Charlier C; Houssin R; Hénichart JP
    Bioorg Med Chem Lett; 2002 Mar; 12(5):779-82. PubMed ID: 11859001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.